Invasive disseminierte aspergillose unter kombinierter immunsuppressiver therapie bei systemischem Lupus erythematodes

Medizinische Klinik

Volumn 91, Issue 12, 1996, Pages 798-801

  Teuber, Gerlinde ^a   Schwarting, Andreas ^a   Mildenberger, Peter ^a   Schmidt Brücken, Georg ^a   Moll, Roland ^a   Bornemann, Antje ^a   Wandel, Evelyn ^a   Wanitschke, Roland ^a,b   Zum Büschenfelde, Karl Hermann Meyer ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GENTAMICIN; IMIPENEM; METRONIDAZOLE; PREDNISOLONE; PREDNISONE;

AGED; ARTICLE; ASPERGILLOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

AGED; ASPERGILLOSIS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; FUNGEMIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; OPPORTUNISTIC INFECTIONS; PREDNISOLONE;

EID: 0030459378     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Austin, H A., J. H. Klippel, J. E Balow, N. G. H. Le Riche, A. D. Steinberg, H Paul, P. H. Plotz, J. L. Decker. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. New Engl. J. Med. 314 (1986), 614-619.
2. Balow, J. E., H. A Austin, C. Tsokos, T. T. Antonovych, A D. Sreinberg, J. H. Klippel: Lupus nephritis. Ann. intern. Med. 106 (1987), 79-94.
3. Bodey, G. P., A. S. Glann. Central nervous system aspergillosis following steroidal therapy for allergic bronchopulmonary aspergillosis. Chest 103 (1993), 299-301.
4. Boeckh, M., G. Höffken, H. Lode: Spektrum pulmonaler Manifestationen von Aspergillosen. Dtsch. med. Wschr. 114 (1989), 1706-1709.
5. Cheigh, J. S., K. H. Stenzel: End-stage renal disease in systemic lupus erythematosus. Amer J. Kidney Dis. 21 (1993), 2-8.
6. Denning, D. W., S. E. Follansbee, M. Scolaro, S. Nortis, H Edelstein, D. A. Stevens: Pulmonary aspergillosis in the acquired immunodeficiency syndrome. New Engl. J. Med. 324 (1991), 654-662.
7. Dewhurst, A. G., M. J. Cooper, S. M. Khan, A. P. Pallet, J. R. E. Dathan: Invasive aspergillosis in immunosuppressed patients: potential of hospital building work. Brit. med. J. 301 (1990), 802-804.
8. Donadio, J. V., R. J. Glassock: Immunosupressive drug therapy in lupus nephritis. Amer. J. Kidney Dis. 21 (1993), 239-250.
9. Gerson, S. L., G. H. Talbot, S. Hurwitz, B. L. Strom, E. J. Lusk, P. A. Cassileth: Prolonged granulocytopenia The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann. intern Med 100 (1984), 345-351.
10. Hovenden, J. L., F. Nicklason, R. A. Barnes: Invasive pulmonary aspergillosis in non-immunocompromised patients. Brit. med. 302 (1991), 583-584.
11. Jarrett, M. P., S. Santhanam, F. Del Greco: The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch. intern. Med. 143 (1983), 1353-1356
12. Kahn, F. W., J. M. Jones, D. M. England: The role of bronchoalveolar lavage in the diagnosis of invasisve pulmonary aspergillosis. Amer. J. clin. Path. 86 (1986), 518-523.
13. Kirsten, D., U. Rieger, M. Amthor, H. Magnussen: Invasive Aspergillose bei kavitärer Lungensarkoidose, Pneumologie 46 (1992), 239-242.
14. Köhler, H., M Girndt, H Dumann, R. Klingel, Immundefekt bei Niereninsuffzienz. Teil I: Klinische Manifestationen. Dtsch. med. Wschr. 118 (1993), 757-761.
15. Köhler, H , M. Girndt, H. Dumann, R. Klingel: Immundefekt bei Niereninsuffizienz. Teil II: Mechanismen des "urämischen" Immundefekts Dtsch. med. Wschr. 118 (1993), 790-795.
16. Mc Cune, W. J., J. Golbus, W. Zeldes, P. Bohlke, R. Dünne, D. A. Fox: Clinical and immunological effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. New Engl. J. Med. 318 (1988), 1423-1431.
17. Meyer, R. D., L. S. Yuong, D. Armstrong, B. Yu: Aspergillosis complicating neoplastic disease. Amer. J. Med. 15 (1973), 6-15
18. Palmer, L. P , H. E. Greenberg, M. J. Schiff: Cortico-steroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 46 (1991) 15-20.
19. Pollack, C. A , L. S. Ibels: Dialysis and transplantation in patients with renal failure due to systemic lupus erythematosus The australian and New Zealand experience. Aust. N. Z. J. Med 17 (1987), 321-325
20. Rodrigues, J , M. S. Niedermann, A. M. Fein, P B. Pai; Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Amer. J. Med. 93 (1992), 29-34.
21. Rogers, T R., K. A. Haynes, R. A. Barnes: Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 336 (1990), 1210-1213.
22. St. Georgiev, V. Treatment and developmental therapeutics in aspergillosis. Respiration 59 (1992), 291-302.
23. Webb, W. R., N. L. Müller, D P. Naidich: High-resolution CT of the lung Raven Press, New York 1992.
24. Yu, L. V., R. R. Muder, A. Poorsattar: Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Amer. J. Med. 81 (1986), 249-254.